These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2538111)

  • 61. Induction of serum antibodies in non-human primates with a killed oncogenic herpesvirus (herpesvirus Saimiri).
    Laufs R; Steinke H
    IARC Sci Publ (1971); 1975; (11 Pt 2):345-51. PubMed ID: 191378
    [No Abstract]   [Full Text] [Related]  

  • 62. Serologic responses of pregnant thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine.
    Bryans JT
    Am J Vet Res; 1980 Nov; 41(11):1743-6. PubMed ID: 6259970
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serologic and molecular comparisons of several equine herpesvirus type 1 strains.
    Turtinen LW; Allen GP; Darlington RW; Bryans JT
    Am J Vet Res; 1981 Dec; 42(12):2099-104. PubMed ID: 6280520
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human monoclonal antibodies neutralizing human cytomegalovirus.
    Masuho Y; Matsumoto Y; Sugano T; Fujinaga S; Minamishima Y
    J Gen Virol; 1987 May; 68 ( Pt 5)():1457-61. PubMed ID: 2437245
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid subtyping of equine herpesvirus 1 with monoclonal antibodies.
    Yeargan MR; Allen GP; Bryans JT
    J Clin Microbiol; 1985 May; 21(5):694-7. PubMed ID: 2987299
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
    J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.
    Burns JW; Siadat-Pajouh M; Krishnaney AA; Greenberg HB
    Science; 1996 Apr; 272(5258):104-7. PubMed ID: 8600516
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of bovine herpesvirus 4 (DN 599) major antigens with monoclonal antibodies and polyclonal immune serum.
    Li H; Shen DT; Burger D; Davis WC; Gorham JR
    Arch Virol; 1991; 119(3-4):225-38. PubMed ID: 1877887
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1985 May; 66 ( Pt 5)():1045-53. PubMed ID: 2987395
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
    Tewari D; Whalley JM; Love DN; Field HJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhancement of neutralizing activity of anti-feline herpesvirus type 1 sera by complement supplementation.
    Horimoto T; Limcumpao JA; Tohya Y; Takahashi E; Mikami T
    Nihon Juigaku Zasshi; 1989 Oct; 51(5):1025-7. PubMed ID: 2558248
    [No Abstract]   [Full Text] [Related]  

  • 74. Antibody response against early antigens in Herpesviridae infections.
    Landini MP
    Eur J Epidemiol; 1985 Mar; 1(1):62-6. PubMed ID: 3021515
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccines for equine herpesvirus type 1.
    Studdert MJ
    Vet Rec; 1983 Apr; 112(14):334. PubMed ID: 6304985
    [No Abstract]   [Full Text] [Related]  

  • 76. [EHV1, to vaccinate or not?].
    Binkhorst GJ; van Oirschot JT; Breukink HJ
    Tijdschr Diergeneeskd; 1985 Mar; 110(5):189-90. PubMed ID: 2984805
    [No Abstract]   [Full Text] [Related]  

  • 77. Potential for immunization against herpesvirus infections with plasma membrane vesicles.
    Pearson GR; Scott RE
    IARC Sci Publ (1971); 1978; (24 Pt 2):1019-25. PubMed ID: 221369
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The proteins of equid herpesvirus 1 (EHV 1) recognised by equine antisera and their ability to promote antibody-dependent cell-mediated cytotoxicity.
    Bridges CG; Edington N
    Tierarztl Prax Suppl; 1987; 2():47-9. PubMed ID: 3035747
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Application of the passive hemagglutination test to the study of equine rhinopneumonitis. II. Serologic study in horses].
    Berrios P; Ibarra L; Riquelme S
    Rev Latinoam Microbiol; 1986; 28(4):339-43. PubMed ID: 3035677
    [No Abstract]   [Full Text] [Related]  

  • 80. Herpesvirus strigis: a new avian herpesvirus. I. Biological properties.
    Bürki F; Burtscher H; Sibalin M
    Arch Gesamte Virusforsch; 1973; 43(1):14-24. PubMed ID: 4367377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.